LEADER 01902nam 22004573 450 001 9910915885503321 005 20240207181600.0 010 $a0-309-08882-8 010 $a0-309-08876-3 035 $a(MiAaPQ)EBC6874739 035 $a(Au-PeEL)EBL6874739 035 $a(CKB)21004382600041 035 $a(NjHacI)9921004382600041 035 $a(EXLCZ)9921004382600041 100 $a20220131d2021 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCountering the Pandemic Threat Through Global Coordination on Vaccines $eThe Influenza Imperative 210 1$aWashington, D.C. :$cNational Academies Press,$d2021. 210 4$dİ2022. 215 $a1 online resource (237 pages) 311 08$aPrint version: Medicine, National Academy of Countering the Pandemic Threat Through Global Coordination on Vaccines Washington, D.C. : National Academies Press,c2021 9780309088701 330 $aIntroduction : the imperative for global investment in influenza vaccines -- The existing global governance landscape for influenza vaccines -- Pathogen sharing for influenza vaccine production -- Technology and manufacturing partnerships -- Influenza vaccine access and financing -- Recommendations and the path forward. 606 $aInfluenza 615 0$aInfluenza. 676 $a616.203 700 $aSands$b Peter$01778723 701 $aWinters$b Janelle$01778724 701 $aSands$b Peter$01778723 712 02$aNational Academies of Sciences, Engineering, and Medicine. 712 02$aCommittee on Global Coordination, Partnerships, and Financing. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910915885503321 996 $aCountering the Pandemic Threat Through Global Coordination on Vaccines$94301649 997 $aUNINA